Dr Robert Hess is working in the field of biochemistry, endocrinology and cancer prevention. He is a specialist in medical technology and epigenetic testing procedures and also a leading expert in A.I. and health optimization. The companies he has founded rank among the global technological leaders in these fields.
Dr Hess advises on various matters of concern related to the Sars-CoV-2 pandemic. His clientele comprises not only distinguished individuals from the cultural, cinematic, political and business spheres, but also governments and non-governmental organizations (NGOs) as well as international bodies set up to deal with the pandemic, such as the Covax Initiative.
Even before the publication in 2001 of the human genome, his health consultancy companies were conducting tests for genetic polymorphisms. Immediately after the award of the 2009 Nobel Prize to the team that discovered the significance of telomeres in the aging process, he developed telomere testing procedures which are still standard today.
Towards the end of the 1990s, Dr Robert Hess was already conducting research into neural networks, which are the basis for A.I. technology. This pioneering work has qualified him as one of the top experts in the role that artificial intelligence and algorithms have to play in health optimization today.
In parallel with his entrepreneurial and consultancy activities, he has been Visiting Professor at St. Elizabeth University (SK) since 2007. He is also a member of Médecins Sans Frontières (Doctors Without Borders) and supports several SOS Children’s Villages in Africa and Colombia.